Elixiron Immunotherapeutics (Cayman) Limited (TPEX:7871)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
114.50
-9.00 (-7.29%)
At close: Aug 18, 2026

TPEX:7871 Statistics

Total Valuation

TPEX:7871 has a market cap or net worth of TWD 15.37 billion. The enterprise value is 14.58 billion.

Market Cap15.37B
Enterprise Value 14.58B

Important Dates

The next estimated earnings date is Friday, November 13, 2026.

Earnings Date Nov 13, 2026
Ex-Dividend Date n/a

Share Statistics

TPEX:7871 has 134.28 million shares outstanding. The number of shares has increased by 256.61% in one year.

Current Share Class 134.28M
Shares Outstanding 134.28M
Shares Change (YoY) +256.61%
Shares Change (QoQ) +422.63%
Owned by Insiders (%) 8.12%
Owned by Institutions (%) 6.04%
Float 90.43M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 135.65
PB Ratio 20.04
P/TBV Ratio 20.43
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 128.64
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.46, with a Debt / Equity ratio of 0.02.

Current Ratio 9.46
Quick Ratio 9.36
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF -0.08
Interest Coverage -275.43

Financial Efficiency

Return on equity (ROE) is -21.37% and return on invested capital (ROIC) is -18.32%.

Return on Equity (ROE) -21.37%
Return on Assets (ROA) -17.11%
Return on Invested Capital (ROIC) -18.32%
Return on Capital Employed (ROCE) -28.37%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.14
Inventory Turnover n/a

Taxes

In the past 12 months, TPEX:7871 has paid 33.94 million in taxes.

Income Tax 33.94M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 81.38
200-Day Moving Average n/a
Relative Strength Index (RSI) 73.60
Average Volume (20 Days) 1,575,123

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, TPEX:7871 had revenue of TWD 113.34 million and -155.83 million in losses. Loss per share was -1.17.

Revenue113.34M
Gross Profit 113.14M
Operating Income -220.07M
Pretax Income -121.89M
Net Income -155.83M
EBITDA -215.13M
EBIT -220.07M
Loss Per Share -1.17
Full Income Statement

Balance Sheet

The company has 808.06 million in cash and 13.06 million in debt, with a net cash position of 795.00 million or 5.92 per share.

Cash & Cash Equivalents 808.06M
Total Debt 13.06M
Net Cash 795.00M
Net Cash Per Share 5.92
Equity (Book Value) 767.09M
Book Value Per Share 5.74
Working Capital 732.70M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -155.03 million and capital expenditures -504,000, giving a free cash flow of -155.53 million.

Operating Cash Flow -155.03M
Capital Expenditures -504,000
Depreciation & Amortization 4.94M
Net Borrowing 623.95M
Free Cash Flow -155.53M
FCF Per Share -1.16
Full Cash Flow Statement

Margins

Gross margin is 99.83%, with operating and profit margins of -194.17% and -137.49%.

Gross Margin 99.83%
Operating Margin -194.17%
Pretax Margin -107.54%
Profit Margin -137.49%
EBITDA Margin -189.81%
EBIT Margin -194.17%
FCF Margin n/a

Dividends & Yields

TPEX:7871 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -256.61%
Shareholder Yield -256.61%
Earnings Yield -1.01%
FCF Yield -1.01%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 5